Table III.
HC (n=31) |
DM (n=42) |
IBM (n=18) |
PM (n=34) |
|
---|---|---|---|---|
Fine speckled | 39% (12)* | 64% (27)* | 61% (11) | 56% (19) |
Homogeneous | 29% (9)** | 10% (4)* | 6% (1) | 0% (0)*** |
Nuclear large/coarse speckled | 13% (4) | 10% (4) | 6% (1) | 3% (1) |
Centromere | 6% (2) | 0% (0) | 0% (0) | 6% (2) |
Nucleolar homogeneous | 6% (2) | 7% (3) | 6% (1) | 18% (6) |
Nucleolar clumpy | 3% (1) | 2% (1) | 6% (1) | 6% (2) |
Topo I speckled | 3% (1) | 0% (0) | 0% (0) | 0% (0) |
Nuclear envelope punctate | 0% (0) | 2% (1) | 11% (2) | 6% (2) |
Nuclear envelope smooth | 0% (0) | 0% (0) | 6% (1) | 0% (0) |
Dense fine speckled | 0% (0) | 2% (1) | 0% (0) | 0% (0) |
Discrete nuclear dots multiple | 0% (0) | 2% (1) | 0% (0) | 3% (1) |
Nucleolar envelope punctate | 0% (0) | 0% (0) | 0% (0) | 3% (1) |
p<0.05,
p<0.01,
p<0.001.
Dichotomous variables were shown as %(n) and compared using the Chi-squared or Fisher’s exact tests, as appropriate. Each group was compared with the healthy comparators.
HC: healthy comparator; DM: dermatomyositis; IBM: inclusion body myositis; PM: polymyositis.